Literature DB >> 29748053

Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14.

Jacob Holechek1, Robert Lease1, Ann-Gerd Thorsell2, Tobias Karlberg2, Caitlin McCadden1, Ryan Grant1, Abby Keen1, Evan Callahan1, Herwig Schüler2, Dana Ferraris3.   

Abstract

A series of diaryl ethers were designed and synthesized to discern the structure activity relationships against the two closely related mono-(ADP-ribosyl)transferases PARP10 and PARP14. Structure activity studies identified 8b as a sub-micromolar inhibitor of PARP10 with ∼15-fold selectivity over PARP14. In addition, 8k and 8m were discovered to have sub-micromolar potency against PARP14 and demonstrated moderate selectivity over PARP10. A crystal structure of the complex of PARP14 and 8b shows binding of the compound in a novel hydrophobic pocket and explains both potency and selectivity over other PARP family members. In addition, 8b, 8k and 8m also demonstrate selectivity over PARP1. Together, this study identified novel, potent and metabolically stable derivatives to use as chemical probes for these biologically interesting therapeutic targets.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ARTD-8; Mono(ADP-ribosyl) transferase; PARP; PARP10; PARP14

Mesh:

Substances:

Year:  2018        PMID: 29748053     DOI: 10.1016/j.bmcl.2018.04.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

Review 1.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

2.  Rational design of selective inhibitors of PARP4.

Authors:  Ilsa T Kirby; Ashley Person; Michael Cohen
Journal:  RSC Med Chem       Date:  2021-10-04

3.  Integrating DNA-encoded chemical libraries with virtual combinatorial library screening: Optimizing a PARP10 inhibitor.

Authors:  Mike Lemke; Hannah Ravenscroft; Nicole J Rueb; Dmitri Kireev; Dana Ferraris; Raphael M Franzini
Journal:  Bioorg Med Chem Lett       Date:  2020-08-05       Impact factor: 2.823

4.  ADP-ribosyltransferases, an update on function and nomenclature.

Authors:  Bernhard Lüscher; Ivan Ahel; Matthias Altmeyer; Alan Ashworth; Peter Bai; Paul Chang; Michael Cohen; Daniela Corda; Françoise Dantzer; Matthew D Daugherty; Ted M Dawson; Valina L Dawson; Sebastian Deindl; Anthony R Fehr; Karla L H Feijs; Dmitri V Filippov; Jean-Philippe Gagné; Giovanna Grimaldi; Sebastian Guettler; Nicolas C Hoch; Michael O Hottiger; Patricia Korn; W Lee Kraus; Andreas Ladurner; Lari Lehtiö; Anthony K L Leung; Christopher J Lord; Aswin Mangerich; Ivan Matic; Jason Matthews; George-Lucian Moldovan; Joel Moss; Gioacchino Natoli; Michael L Nielsen; Mario Niepel; Friedrich Nolte; John Pascal; Bryce M Paschal; Krzysztof Pawłowski; Guy G Poirier; Susan Smith; Gyula Timinszky; Zhao-Qi Wang; José Yélamos; Xiaochun Yu; Roko Zaja; Mathias Ziegler
Journal:  FEBS J       Date:  2021-07-29       Impact factor: 5.622

5.  The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.

Authors:  Matthew E Grunewald; Yating Chen; Chad Kuny; Takashi Maejima; Robert Lease; Dana Ferraris; Masanori Aikawa; Christopher S Sullivan; Stanley Perlman; Anthony R Fehr
Journal:  PLoS Pathog       Date:  2019-05-16       Impact factor: 6.823

Review 6.  The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism.

Authors:  Magdolna Szántó; Peter Bai
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 7.  Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives.

Authors:  Palmiro Poltronieri; Angela Celetti; Luca Palazzo
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

8.  The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19).

Authors:  Amanda L Tauber; Stephanie S Schweiker; Stephan M Levonis
Journal:  Future Med Chem       Date:  2021-01-20       Impact factor: 3.808

9.  Genome-wide CRISPR synthetic lethality screen identifies a role for the ADP-ribosyltransferase PARP14 in DNA replication dynamics controlled by ATR.

Authors:  Ashna Dhoonmoon; Emily M Schleicher; Kristen E Clements; Claudia M Nicolae; George-Lucian Moldovan
Journal:  Nucleic Acids Res       Date:  2020-07-27       Impact factor: 16.971

10.  Synthesis of 3-Substituted Pyrrolidines via Palladium-Catalyzed Hydroarylation.

Authors:  Joseph B Sweeney; Julien Doulcet; Bimod Thapa
Journal:  iScience       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.